Skip to main content

Table 1 Demographics for the healthy control and BAV cohorts

From: Systolic reverse flow derived from 4D flow cardiovascular magnetic resonance in bicuspid aortic valve is associated with aortic dilation and aortic valve stenosis: a cross sectional study in 655 subjects

 

Healthy control

TAV + dilation

All BAV

BAV − No AR

BAV âˆ’ mild AR

BAV âˆ’ moderate AR

BAV âˆ’ severe AR

p-value

Group size

25

120

510

216

171

87

36

–

Age (years)

49 ± 12

61.1 ± 10.7□

51.5 ± 13.5

52.5 ± 14

52.2 ± 12.6

48.8 ± 13.7

48.3 ± 12

< 0.001

BMI

26 ± 5

28.9 ± 5.7

27.9 ± 5.6

28.1 ± 6.4

27.9 ± 5.2

27.5 ± 4.3

28.3 ± 4.1

0.4

Female (%)

24.0

21.7

24.4

35.1∆○◊

20.7â–¡

11.5â–¡

8.3â–¡

< 0.001

LVEF (%)

56.1 ± 6.2

59.1 ± 5.8□

60.7 ± 7.9

62 ± 7.2*◊

60.5 ± 7.7*◊

59.8 ± 8.7

55.2 ± 9

< 0.001

MAAD (mm)

–

40.7 ± 3.5

42.8 ± 5

42.2 ± 4.9

43.5 ± 5.2

42.9 ± 4.6

43.2 ± 4.8

< 0.001

SOV (mm)

–

42.1 ± 5.1□

41.1 ± 4.9

40 ± 5

41.7 ± 4.7

42 ± 4.9

42.6 ± 4.2

< 0.001

HR

64 ± 9

64 ± 11

69 ± 12

68 ± 12

69 ± 12

69 ± 13

69 ± 2

0.5

CO

5.3 ± 1.1

5.3 ± 1.5□

7.8 ± 12.4

7.6 ± 15.3

6.5 ± 1.9

10.4 ± 18

9.4 ± 2.4

0.04

SV

84.5 ± 16.7

84.4 ± 25.5

101 ± 33

88.7 ± 27∆○◊

101 ± 30□○◊

117 ± 30*□∆◊

140 ± 34*□∆○

< 0.001

LVESV

67 ± 17.7

59.2 ± 20.9

69.3 ± 37

56.6 ± 27*∆○◊

68.9 ± 33□○◊

79.6 ± 32.3□∆◊

124 ± 57*□∆○

< 0.001

LVEDV

152 ± 29

144 ± 43

170 ± 61

146 ± 47∆○◊

170 ± 53□○◊

194 ± 52*□∆◊

261 ± 79*□∆○

< 0.001

No AS

–

120

308

128

106

55

19

0.7

Mild AS

–

–

55

19

23

11

2

0.4

Moderate AS

–

–

68

27

19

16

6

0.4

Severe AS

–

–

79

42â—‹

23

5â—Šâ–¡

9â—‹

0.007

  1. Significant difference compared to *—Healthy Control, □—No AR, ∆—Mild AR, ○—Moderate AR, ◊—Severe AR
  2. One way ANOVA compared healthy controls, TAV patients with dilation, and AR subgroups (p-value reported). The legend indicates which group a value is significantly different (p < 0.005) from. TAV + dilation was only compared with BAV âˆ’ no AR group. Blood pressure was not available in most subjects and was excluded from this table. AR, aortic regurgitation; BAV, bicuspid aortic valve; CO, cardial output; LVEDV, left ventricular end-diastolic volume, LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume, MAAD, mid ascending aorta diameter; SV, stroke volume; TAV, trileaflet aortic valve